Virtual reality is the creation of computer generated simulated virtual environment to provide real-life sensory experience to the person. It creates a highly immersive, visual and three dimensional environment, in which an individual is able to manipulate virtual objects and perform a series of tasks. The environment is either of real or simulated world, in which an individual is able to feel and interact with the objects and characters. Virtual treatment has certain advantages over conventional methods of treatment such as virtual treatment often eliminates the use of drugs and complex invasive surgical procedures for treatment, thus saving the cost and time. The major factors driving the global virtual reality in healthcare market are; rising incidences of neurological disorders, increasing demand for innovative diagnostic techniques and increasing disease awareness. Moreover, recent advancement in the field of information technology such as computer, laptop, internet connectivity and mobile applications, would further fuel the market growth. However, high cost of treatment, lack of skilled workers and inaccessibility to virtual reality technology in developing economies are likely to hinder the market growth.
The global virtual reality in the healthcare market is segmented on the basis of technology, application and geography. On the basis of technology, the market is segmented into, Full Immersive VR, Semi-Immersive VR and Non- Immersive VR. The market, on the basis of application segmented into Surgery simulation, Phobia treatment, Robotic surgery, Education and Training, Visualization and Rehabilitation, Treatment of Post-Traumatic Stress Disorder (PTSD), Treatment of Autism, Diagnosis of cognitive disorders and others. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.
Some of the strategies adopted by top industry players include new product launches. For instance, in April 2015, Samsung collaborated with Nuance, a software developer, to integrate a new virtual assistant clinical documentation technology to the Samsung Gear S smartwatch with a view to assist medical professionals. CAE Healthcare, recently launched obstetrics and a gynecology simulation ultrasound training system in India. In 2014, Surgical Theater, received the FDA approval for SNAP device, a virtual reality device for surgical procedures.The companies profiled in this report include; Virtalis Ltd, CAE Healthcare, GE Healthcare, Virtual Realities Ltd, Qualcomm Technologies, Inc., Samsung, Vuzix Corporation, Mimic Technologies Inc, WorldViz, LLC., and Brainlab AG.
KEY MARKET BENEFITS
Comprehensive analysis of factors that drive and restrict the growth of the global virtual reality in healthcare market are provided
The report provides a quantitative analysis of the current market along with estimations through 2014-2020 that helps identify the prevailing market opportunities
An in-depth analysis of key segments of the market demonstrates the types of technologies and applications that are currently being used along with the variants that would gain prominence in future
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
Region-wise virtual reality healthcare market conditions are comprehensively analysed in the report
KEY MARKET SEGMENTS:
The global virtual reality in healthcare market is segmented below:
Global Virtual Reality in Healthcare Market - By Technology
Full Immersive VR
Non- Immersive VR
Global Virtual Reality in Healthcare Market - By Application
Education And Training
Visualization And Rehabilitation
Treatment of Post-Traumatic Stress Disorder (PTSD)
Treatment of Autism
Diagnosis of cognitive disorders
Global Virtual Reality in Healthcare Market - By Geography
SIMILAR MARKET STUDIES
Ovarian Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Cancer. Report includes an overview of trial numbers and ...
May 2016 | $2500 | View Details >>
Summary ProNoxis AB (ProNoxis) is a biotechnology company. The company develops small-molecule drugs to treat chronic inflammation. It produces drug for oral administration in human patients who are suffering from autoimmune inflammatory disease. Its product includes NOX2-activating drug. ProNoxis’s NOX2-produced ROS is a natural mechanism for the immune system to control ...
July 2015 | $250 | View Details >>
Market analysis of the nail care market Technavios market research analyst predicts the global nail care market to reach a market value of around USD 9 billion by the end of 2019. The rising demand for nail polish among the younger population is one of the primary drivers of the market. ...
January 2016 | $2500 | View Details >>
Summary RhinoCyte, Inc. (RhinoCyte) is a biotechnology company. The company develops and commercializes diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases. Its technologies include biopsy, processing, cryo-preservation, harvesting, isolation and engraftment of adult progenitors (stem cells) into the site of injury. RhinoCyte’s technology facilitates ...
July 2015 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research